News

Supremex Schedules Conference Call and Annual Meeting Announcement

Supremex Schedules Conference Call and Annual Meeting Announcement

Supremex Announces Important Dates for Shareholders

Supremex Inc. is gearing up for important events that shareholders and interested parties won't want to miss. As one of the prominent manufacturers and marketers in North America, known for its envelopes and dynamic paper-based packaging solutions, the company is set to unveil its first-quarter results for the year. These results are pivotal for investors and stakeholders who are keen on understanding the company's financial health and future trajectory.

Details of the Conference Call

The much-anticipated conference call will take place on May 8, where Supremex will release its financial results for the first quarter ending March 31. Participants are encouraged to join the call promptly at 9:00 a.m. (Eastern Time). This event will be an excellent opportunity for the investment community to gain insights into the company’s performance and strategic direction.

How to Join the Conference Call

Attendance is reserved for the professional investment community. Interested parties can dial in to join the conversation. Though it is vital for participants to connect at least five minutes before the call starts, key dialing options are available:

For those in Toronto and international participants, the number to dial is 647-846-8776. North American participants can connect toll-free using the number 1-833-752-3804.

Access to Conference Call Replays

For those unable to attend the live event, a replay will be accessible on Supremex's website, ensuring that all stakeholders have the opportunity to catch up on the important discussions. The replay can be accessed by dialing 1-855-669-9658 or 412-317-0088 and entering the code 3698048. This recording will be available for a limited time, specifically until May 15, making it an ideal chance to stay informed.

Annual Meeting of Shareholders

In addition to the conference call, Supremex will host its annual meeting of shareholders on the same day at 11:00 a.m. The meeting will be held at Stikeman Elliott LLP, located at 1155 René-Lévesque Boulevard West, 41st Floor in Montreal.

Importance of the Annual Meeting

This annual meeting is crucial as it allows shareholders to engage directly with the company’s leadership. It provides insights into the company's strategy, financial results, and future endeavors. Shareholders are encouraged to attend, participate, and voice their opinions and inquiries.

About Supremex Inc.

Supremex Inc. stands as a leader in the North American envelope manufacturing sector, while also expanding its portfolio to include a wider range of paper-based packaging solutions. With nine manufacturing facilities scattered across four provinces in Canada and five additional ones located in three states in the U.S., Supremex employs around 900 dedicated individuals.

The company’s extensive operational scope enables it to efficiently craft and distribute envelope and packaging solutions tailored to meet the needs of various clients, including major corporations, direct mailers, SMEs, government entities, and more. This adaptability reflects Supremex's commitment to quality and customer satisfaction.

Connecting with Supremex

For more details about the company and its latest offerings, investors and customers are encouraged to visit their official website at www.supremex.com. This platform serves as a hub for the latest news and updates related to the company.

Company Contact Information

Inquiries can be directed to:

Stewart Emerson
President and Chief Executive Officer
Email: investors@supremex.com
Phone: 416-675-9370, extension 8344

Martin Goulet, M.Sc., CFA
MBC Capital Markets Advisors
Email: mgoulet@maisonbrison.com
Phone: 514-731-0000, extension 229

Frequently Asked Questions

What will be discussed during the conference call?

The conference call will focus on Supremex's financial results for the first quarter and provide insights into the company’s strategic direction.

How can I participate in the conference call?

Interested participants can dial specific numbers to join the call, with instructions provided in the announcement.

Is there a replay of the conference call available?

Yes, a replay will be available on Supremex's website following the live call.

What is the significance of the annual meeting?

The annual meeting allows shareholders to engage with the company’s leaders and discuss important topics concerning the company’s future.

Where can I find more information about Supremex?

Detailed information can be found on Supremex's official website, which offers updates and insights about the company's operations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Empowering Women in Cannabis: Toronto's Radicle Femmes Event

Updated Category News Views 130

Empowerment Through Connection: Radicle Femmes Returns Radicle Femmes is set to make waves once again as it returns to Toronto, focusing on the empowerment, celebration, and advancement of women within the cannabis industry. This much-anticipated event will occur just ahead of International Women's Day, providing a platform for women and their allies to connect, share...

Continue Reading
Join the 2025 Tour For Life®: A Celebration of Animal Rescue

Updated Category News Views 450

Join the 2025 Tour For Life®: A Celebration of Animal Rescue North Shore Animal League America is gearing up for a remarkable journey with its 25th Annual Tour For Life®. This event is known as the world's largest cooperative pet adoption initiative, designed to shine a light on the importance of animal rescue and adoption. The tour is scheduled to traverse the country,...

Continue Reading
H.I.G. Capital Expands Portfolio with Kantar Media Acquisition

Updated Category News Views 198

H.I.G. Capital Completes Acquisition of Kantar Media H.I.G. Capital, a prestigious global alternative investment firm managing approximately $70 billion in capital, is thrilled to announce the successful acquisition of Kantar Media. This strategic move not only underscores H.I.G.'s commitment to growth but also establishes Kantar Media as a cornerstone in their expansive...

Continue Reading
Transforming $1000 Into a Fortune: Analog Devices Journey

Updated Category News Views 334

The Growth of $1000 in Analog Devices Stock Investing can sometimes feel like a gamble, but what if you made a decision 20 years ago that turned out to be incredibly rewarding? Let’s look at the investment story of Analog Devices (NASDAQ: ADI) and its transformative journey over two decades. Understanding Analog Devices Analog Devices is a leading global supplier of...

Continue Reading
Takeda and Keros Therapeutics Team Up for Cancer Treatment

Updated Category News Views 226

Takeda Partners with Keros Therapeutics for Elritercept Takeda has taken a significant step in strengthening its oncology pipeline through an exclusive licensing agreement with Keros Therapeutics, Inc. This collaboration focuses on furthering the development, manufacturing, and commercialization of elritercept, designed to tackle anemia linked to certain hematologic...

Continue Reading